212 related articles for article (PubMed ID: 10843168)
1. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.
Vahl N; Juul A; Jørgensen JO; Orskov H; Skakkebaek NE; Christiansen JS
J Clin Endocrinol Metab; 2000 May; 85(5):1874-81. PubMed ID: 10843168
[TBL] [Abstract][Full Text] [Related]
2. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.
Nørrelund H; Vahl N; Juul A; Møller N; Alberti KG; Skakkebaek NE; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2000 May; 85(5):1912-7. PubMed ID: 10843174
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
4. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
5. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
[TBL] [Abstract][Full Text] [Related]
6. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial.
Mauras N; Pescovitz OH; Allada V; Messig M; Wajnrajch MP; Lippe B;
J Clin Endocrinol Metab; 2005 Jul; 90(7):3946-55. PubMed ID: 15855257
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
8. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
Sneppen SB; Hoeck HC; Kollerup G; Sørensen OH; Laurberg P; Feldt-Rasmussen U
Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
[TBL] [Abstract][Full Text] [Related]
10. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.
Attanasio AF; Lamberts SW; Matranga AM; Birkett MA; Bates PC; Valk NK; Hilsted J; Bengtsson BA; Strasburger CJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):82-8. PubMed ID: 8989238
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
Underwood LE; Attie KM; Baptista J;
J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
[TBL] [Abstract][Full Text] [Related]
12. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.
Janssen JA; van der Toorn FM; Hofland LJ; van Koetsveld P; Broglio F; Ghigo E; Lamberts SW; Jan van der Lely A
Eur J Endocrinol; 2001 Dec; 145(6):711-6. PubMed ID: 11720895
[TBL] [Abstract][Full Text] [Related]
13. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
[TBL] [Abstract][Full Text] [Related]
14. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients.
Attanasio AF; Howell S; Bates PC; Frewer P; Chipman J; Blum WF; Shalet SM
J Clin Endocrinol Metab; 2002 Jul; 87(7):3368-72. PubMed ID: 12107251
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
[TBL] [Abstract][Full Text] [Related]
16. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
[TBL] [Abstract][Full Text] [Related]
17. Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults.
Ezzat S; Fear S; Gaillard RC; Gayle C; Landy H; Marcovitz S; Mattioni T; Nussey S; Rees A; Svanberg E
J Clin Endocrinol Metab; 2002 Jun; 87(6):2725-33. PubMed ID: 12050241
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
Johannsson G; Albertsson-Wikland K; Bengtsson BA
J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
[TBL] [Abstract][Full Text] [Related]
19. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
20. The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study.
Vahl N; Jørgensen JO; Hansen TB; Klausen IB; Jurik AG; Hagen C; Christiansen JS
Int J Obes Relat Metab Disord; 1998 Jun; 22(6):529-36. PubMed ID: 9665673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]